# Texas Capital Bancshares Inc: financial statements, quarterly

TCBI · TXSE · CIK 1077428 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tcbi.md) · [Financials](/companies/tcbi/financials.md) · [Filings](/companies/tcbi/filings.md) · [Insiders](/companies/tcbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tcbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [202 d](/filings/0001077428-24-000040.md) | [202](/filings/0001077428-24-000092.md) | [205](/filings/0001077428-24-000146.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.3 d](/filings/0001077428-26-000010.md) | [8.8](/filings/0001077428-25-000078.md) | [16.9](/filings/0001077428-25-000136.md) | [(18.7)](/filings/0001077428-25-000145.md) | [22.5 d](/filings/0001077428-26-000010.md) | [13.4](/filings/0001077428-26-000052.md) | [24.9](/filings/0001077428-26-000059.md) | [32.6](/filings/0001077428-26-000080.md) | [31.6 d](/filings/0001077428-26-000010.md) | [20.6](/filings/0001077428-26-000052.md) | [27.1](/filings/0001077428-26-000059.md) | [32.0](/filings/0001077428-26-000080.md) |
| Net income | $m | [20.2 d](/filings/0001077428-26-000010.md) | [26.1](/filings/0001077428-25-000078.md) | [41.7](/filings/0001077428-25-000136.md) | [(61.3)](/filings/0001077428-25-000145.md) | [71.0 d](/filings/0001077428-26-000010.md) | [47.0](/filings/0001077428-26-000052.md) | [77.3](/filings/0001077428-26-000059.md) | [105](/filings/0001077428-26-000080.md) | [101 d](/filings/0001077428-26-000010.md) | [73.8](/filings/0001077428-26-000052.md) | [84.9](/filings/0001077428-26-000059.md) | [104](/filings/0001077428-26-000080.md) |
| Diluted EPS | $ per share | not reported | [0.46](/filings/0001077428-25-000078.md) | [0.80](/filings/0001077428-25-000136.md) | [(1.41)](/filings/0001077428-25-000145.md) | not reported | [0.92](/filings/0001077428-26-000052.md) | [1.58](/filings/0001077428-26-000059.md) | [2.18](/filings/0001077428-26-000080.md) | not reported | [1.56](/filings/0001077428-26-000052.md) | [1.83](/filings/0001077428-26-000059.md) | [2.28](/filings/0001077428-26-000080.md) |
| Basic EPS | $ per share | not reported | [0.46](/filings/0001077428-25-000078.md) | [0.80](/filings/0001077428-25-000136.md) | [(1.42)](/filings/0001077428-25-000145.md) | not reported | [0.93](/filings/0001077428-26-000052.md) | [1.59](/filings/0001077428-26-000059.md) | [2.21](/filings/0001077428-26-000080.md) | not reported | [1.58](/filings/0001077428-26-000052.md) | [1.85](/filings/0001077428-26-000059.md) | [2.30](/filings/0001077428-26-000080.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [28.4](/filings/0001077428-25-000036.md) | [29.2](/filings/0001077428-24-000092.md) | [29.9](/filings/0001077428-24-000146.md) | [31.6](/filings/0001077428-24-000181.md) | [30.7](/filings/0001077428-26-000010.md) | [31.4](/filings/0001077428-25-000078.md) | [31.9](/filings/0001077428-25-000136.md) | [32.5](/filings/0001077428-25-000145.md) | [31.5](/filings/0001077428-26-000080.md) | [33.5](/filings/0001077428-26-000052.md) | [33.9](/filings/0001077428-26-000059.md) | [32.3](/filings/0001077428-26-000080.md) |
| Total liabilities | $bn | [25.2](/filings/0001077428-25-000036.md) | [26.0](/filings/0001077428-24-000092.md) | [26.7](/filings/0001077428-24-000146.md) | [28.3](/filings/0001077428-24-000181.md) | [27.4](/filings/0001077428-26-000010.md) | [27.9](/filings/0001077428-25-000078.md) | [28.4](/filings/0001077428-25-000136.md) | [28.9](/filings/0001077428-25-000145.md) | [27.9](/filings/0001077428-26-000080.md) | [29.9](/filings/0001077428-26-000052.md) | [30.3](/filings/0001077428-26-000059.md) | [28.9](/filings/0001077428-26-000080.md) |
| Long-term debt | $bn | [0.9](/filings/0001077428-25-000036.md) | [0.9](/filings/0001077428-24-000092.md) | [0.7](/filings/0001077428-24-000146.md) | [0.7](/filings/0001077428-24-000181.md) | [0.7](/filings/0001077428-26-000010.md) | [0.7](/filings/0001077428-25-000078.md) | [0.6](/filings/0001077428-25-000136.md) | [0.6](/filings/0001077428-25-000145.md) | [0.6](/filings/0001077428-26-000080.md) | [0.9](/filings/0001077428-26-000052.md) | [0.5](/filings/0001077428-26-000059.md) | [0.5](/filings/0001077428-26-000080.md) |
| Shareholders' equity | $bn | [3.2](/filings/0001077428-26-000010.md) | [3.2](/filings/0001077428-25-000136.md) | [3.2](/filings/0001077428-25-000145.md) | [3.4](/filings/0001077428-25-000145.md) | [3.4](/filings/0001077428-26-000080.md) | [3.4](/filings/0001077428-26-000059.md) | [3.5](/filings/0001077428-26-000080.md) | [3.6](/filings/0001077428-26-000080.md) | [3.6](/filings/0001077428-26-000080.md) | [3.6](/filings/0001077428-26-000059.md) | [3.6](/filings/0001077428-26-000080.md) | [3.5](/filings/0001077428-26-000080.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [188 d](/filings/0001077428-26-000010.md) | [95.8](/filings/0001077428-25-000078.md) | [33.3 d](/filings/0001077428-25-000136.md) | [333 d](/filings/0001077428-25-000145.md) | [18.2 d](/filings/0001077428-26-000010.md) | [0.4](/filings/0001077428-26-000052.md) | [63.0 d](/filings/0001077428-26-000059.md) | [166 d](/filings/0001077428-26-000080.md) | [130 d](/filings/0001077428-26-000010.md) | [87.5](/filings/0001077428-26-000052.md) | [103 d](/filings/0001077428-26-000059.md) | [207 d](/filings/0001077428-26-000080.md) |
| Capital expenditure | $m | [3.7 d](/filings/0001077428-26-000010.md) | [20.0](/filings/0001077428-25-000078.md) | [22.2 d](/filings/0001077428-25-000136.md) | [15.2 d](/filings/0001077428-25-000145.md) | [7.4 d](/filings/0001077428-26-000010.md) | [2.4](/filings/0001077428-26-000052.md) | [5.5 d](/filings/0001077428-26-000059.md) | [5.0 d](/filings/0001077428-26-000080.md) | [(0.3) d](/filings/0001077428-26-000010.md) | [1.4](/filings/0001077428-26-000052.md) | [10.0 d](/filings/0001077428-26-000059.md) | [(0.9) d](/filings/0001077428-26-000080.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001077428-26-000080.md) | not reported | not reported | not reported | [8.6 d](/filings/0001077428-26-000080.md) |
| Share repurchases | $m | [44.8 d](/filings/0001077428-26-000010.md) | [31.5](/filings/0001077428-25-000078.md) | [50.0 d](/filings/0001077428-25-000136.md) | [0.0 d](/filings/0001077428-25-000145.md) | [(0.0) d](/filings/0001077428-26-000010.md) | [31.2](/filings/0001077428-26-000052.md) | [21.0 d](/filings/0001077428-26-000059.md) | [7.1 d](/filings/0001077428-26-000080.md) | [127 d](/filings/0001077428-26-000010.md) | [75.1](/filings/0001077428-26-000052.md) | [23.6 d](/filings/0001077428-26-000059.md) | [103 d](/filings/0001077428-26-000080.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.9](/filings/0001077428-24-000092.md) | [48.4](/filings/0001077428-24-000146.md) | [48.5](/filings/0001077428-24-000181.md) | [47.7](/filings/0001077428-25-000078.md) | [46.9](/filings/0001077428-25-000136.md) | [46.6](/filings/0001077428-25-000145.md) | [46.6](/filings/0001077428-26-000052.md) | [46.2](/filings/0001077428-26-000059.md) | [46.2](/filings/0001077428-26-000080.md) | [44.6](/filings/0001077428-26-000052.md) | [44.1](/filings/0001077428-26-000059.md) | [43.6](/filings/0001077428-26-000080.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,430,456 at 2026-10-20, from the cover of the [10-Q filed 2026-10-22](/filings/0001077428-26-000080.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.